Clinical effects of GB-115 in patients with Generalized Anxiety Disorder
Authors not yet confirmed · 2022 · European Psychiatry. 65(Suppl 1):S388
What does this source report?
A conference post-hoc analysis of 25 patients reported lower anxiety and fatigue scores over 21 days. Its relationship to the earlier pilot must be resolved before treating it as independent evidence.
- Population and setting
- 25 patients; uncontrolled conference report
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- See source; English abstract or translated patent text where available
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Conference abstract, not a full clinical report.
- No placebo comparison; possible overlap with the 31-patient pilot.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Selected text reviewed
Related-report group: gb115-pilot-possible-overlap. Reports in this group are not assumed to be independent trials.
Source access and review scope
Selected original-source text checked; full methodological review pending.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Source provenance: Conference abstract
Cite and trace this record
Original source: Author unconfirmed. Clinical effects of GB-115 in patients with Generalized Anxiety Disorder European Psychiatry. 65(Suppl 1):S388 2022.
Molekul research summary: https://molekul.io/research/rp-gb115-conference-2022. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry